Antígeno carbohidrato 125 (CA125) como marcador pronóstico en ancianos con insuficiencia cardiaca aguda y fracción de eyección preservada

Llàcer, Pau; Núñez, Julio; Manzano, Luis; Cepeda Rodrigo, José María; Salamanca Bautista, Prado; Trullás Vila, Joan Carles; Guzmán García, Marcos; Quirós López, Raúl; López Reboiro, Manuel Lorenzo; Montero-Pérez-Barquero, Manuel.
Med. clín (Ed. impr.) ; 159(4): 164-170, agosto 2022. tab, graf
Artigo em Espanhol | IBECS (Espanha) | ID: ibc-206656

Documentos relacionados

  1. Carbohydrate antigen 125 (CA125) as a prognostic marker in the elderly with acute heart failure and preserved ejection fraction.
  2. Prognostic significance of carbohydrate antigen 125 in stage D heart failure.
  3. Optimal carbohydrate antigen 125 cutpoint for identifying low-risk patients after admission for acute heart failure.
  4. Prognostic value of carbohydrate antigen 125 in patients undergoing surgical left ventricular reconstruction.
  5. Antigen carbohydrate 125 as a biomarker in heart failure: a narrative review.
  6. CA125 but not NT-proBNP predicts the presence of a congestive intrarenal venous flow in patients with acute heart failure.
  7. Prognostic value of carbohydrate antigen 125 combined with N-terminal pro B-type natriuretic peptide in patients with acute heart failure.
  8. Clinical utility of antigen carbohydrate 125 for planning the optimal length of stay in acute heart failure.
  9. Association of normalization of postoperative carbohydrate antigen 125 levels with treatment failure following uterine artery embolization for adenomyosis.
  10. Prognostic value of NT-proBNP and CA125 across glomerular filtration rate categories in acute heart failure.